Brain Cancer Trial, RecruitingNCT05504772Sponsor: Australian & New Zealand Children's Haematology/Oncology GroupCondition: Brain Cancer
Printed from Voxsanity (voxsanity.com.au) — NCT05504772 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
AI generated eligibility summary.
Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source.
How we use AI
Who might be able to join this trial:
People who are under 18 years old (note: in some cases, people aged 19–25 with a childhood cancer such as neuroblastoma may also be considered, at the discretion of the Study Chair or their representative)
People who are expected to live for more than 6 weeks at the time of joining the trial
People for whom a signed and dated consent form for study enrolment has been completed — either by the participant themselves if they are 18 or older, or by a parent or guardian if the participant is under 18
People for whom a separate signed and dated consent form has been completed regarding genetic testing and the option to receive those genetic results back
Who may not be able to join:
There are no specific exclusion criteria listed in the source information (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Voxsanity
Clinical trials and treatments, explained plainly · voxsanity.com.au
Date:
To: My Doctor
Re: Clinical trial enquiry
I am writing to enquire about the following clinical trial which may be relevant to my care:
Trial: NCT05504772
Sponsor: Australian & New Zealand Children's Haematology/Oncology Group
Phase: Not Applicable
Status: Recruiting
Condition: Brain Cancer
Trial contact: +61 2 9382 3102
More information: https://clinicaltrials.gov/study/NCT05504772
Eligibility summary (AI generated)
Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.
Who might be able to join this trial:
People who are under 18 years old (note: in some cases, people aged 19–25 with a childhood cancer such as neuroblastoma may also be considered, at the discretion of the Study Chair or their representative)
People who are expected to live for more than 6 weeks at the time of joining the trial
People for whom a signed and dated consent form for study enrolment has been completed — either by the participant themselves if they are 18 or older, or by a parent or guardian if the participant is under 18
People for whom a separate signed and dated consent form has been completed regarding genetic testing and the option to receive those genetic results back
Who may not be able to join:
There are no specific exclusion criteria listed in the source information (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.
This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Australian & New Zealand Children's Haematology/Oncology Group
Registry
ClinicalTrials.gov
Start date
16 December 2022
Est. completion
1 July 2025
Where this trial is recruiting
🇦🇺 Australia
🇳🇿 New Zealand
9 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Utility of recommended personalized therapy for HR childhood cancer patients.; Utility of recommended personalized therapy for non-HR childhood cancer patients.
Can't join this trial?
Expanded access pathways
If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.